Q4 2022 Cara Therapeutics Inc Earnings Call
Participants Christopher A. Posner; President, CEO & Director; Cara Therapeutics, Inc. Joana Goncalves; Chief Medical Officer; Cara Therapeutics, Inc. Matthew Murphy Ryan D. Maynard; CFO; Cara The...
6.46 | |
6.41 | |
- | |
6.46 | |
6.4001 | |
4.79-9.2474 | |
15 103 M | |
8.5733 | |
2 253 M | |
40 840 M | |
0.211 | |
0.0372 | |
1.0867 |
No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.
Participants Christopher A. Posner; President, CEO & Director; Cara Therapeutics, Inc. Joana Goncalves; Chief Medical Officer; Cara Therapeutics, Inc. Matthew Murphy Ryan D. Maynard; CFO; Cara The...
By Geoffrey Smith Investing.com -- Shares in Fresenius (ETR:FREG) fell the most in five months in Frankfurt on Wednesday, as a gloomy outlook for the coming year, poor results for 2022 and another ch...